Acute myocardial infarction in a patient positive for lupus anticoagulant: a case report.
Antiphospholipid Syndrome
/ blood
Biomarkers
/ blood
Coronary Stenosis
/ diagnostic imaging
Coronary Thrombosis
/ diagnostic imaging
Drug-Eluting Stents
Fibrinolytic Agents
/ therapeutic use
Humans
Lupus Coagulation Inhibitor
/ blood
Male
Middle Aged
Percutaneous Coronary Intervention
/ instrumentation
Risk Factors
ST Elevation Myocardial Infarction
/ diagnostic imaging
Treatment Outcome
Acute myocardial infarction
Antiphospholipid syndrome
Atherosclerosis
Systemic lupus erythematosus
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
12 07 2019
12 07 2019
Historique:
received:
11
09
2018
accepted:
09
07
2019
entrez:
14
7
2019
pubmed:
14
7
2019
medline:
19
5
2020
Statut:
epublish
Résumé
Autoimmune diseases, such as systemic lupus erythematosus (SLE), are associated with thrombosis and atherosclerosis. Presence of lupus anticoagulant is an independent risk factor for atherosclerotic diseases. A 56-year-old man with past history of hypertension, and cerebral infarction was admitted to our hospital owing to acute chest pain. He was diagnosed with acute myocardial infarction based on his symptoms and electrocardiogram results, which demonstrated ST elevation in the precordial leads. Coronary angiography images revealed total occlusion at the proximal site of the left anterior descending artery. A drug-eluting stent was deployed, which successfully recovered coronary blood flow. The patient had fever of unknown cause when he was 30 years old; on admission, he presented with a low-grade fever and reddish exanthema affecting both cheeks. Based on his physical signs as well as elevated antinuclear antibodies (anti-double-stranded DNA), decreased lymphocytes, and a positive direct Coombs test, he was diagnosed with SLE. Owing to a positive lupus anticoagulant test, he was also suspected to have antiphospholipid syndrome (APS). Triple antithrombotic therapy, including dual antiplatelet therapy with aspirin and clopidogrel during coronary stenting and single anticoagulation therapy with warfarin, was initiated. Careful diagnosis of autoimmune diseases should be performed in patients with thrombosis and atherosclerosis. Moreover, risk factors for coronary artery disease should be strictly controlled in patients with APS.
Sections du résumé
BACKGROUND
Autoimmune diseases, such as systemic lupus erythematosus (SLE), are associated with thrombosis and atherosclerosis. Presence of lupus anticoagulant is an independent risk factor for atherosclerotic diseases.
CASE PRESENTATION
A 56-year-old man with past history of hypertension, and cerebral infarction was admitted to our hospital owing to acute chest pain. He was diagnosed with acute myocardial infarction based on his symptoms and electrocardiogram results, which demonstrated ST elevation in the precordial leads. Coronary angiography images revealed total occlusion at the proximal site of the left anterior descending artery. A drug-eluting stent was deployed, which successfully recovered coronary blood flow. The patient had fever of unknown cause when he was 30 years old; on admission, he presented with a low-grade fever and reddish exanthema affecting both cheeks. Based on his physical signs as well as elevated antinuclear antibodies (anti-double-stranded DNA), decreased lymphocytes, and a positive direct Coombs test, he was diagnosed with SLE. Owing to a positive lupus anticoagulant test, he was also suspected to have antiphospholipid syndrome (APS). Triple antithrombotic therapy, including dual antiplatelet therapy with aspirin and clopidogrel during coronary stenting and single anticoagulation therapy with warfarin, was initiated.
CONCLUSIONS
Careful diagnosis of autoimmune diseases should be performed in patients with thrombosis and atherosclerosis. Moreover, risk factors for coronary artery disease should be strictly controlled in patients with APS.
Identifiants
pubmed: 31299896
doi: 10.1186/s12872-019-1153-9
pii: 10.1186/s12872-019-1153-9
pmc: PMC6626341
doi:
Substances chimiques
Biomarkers
0
Fibrinolytic Agents
0
Lupus Coagulation Inhibitor
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
167Références
Am J Emerg Med. 2014 Feb;32(2):197.e3-5
pubmed: 24176588
Curr Rheumatol Rep. 2013 May;15(5):324
pubmed: 23519891
Am J Cardiol. 2019 Jan 15;123(2):227-232
pubmed: 30424870
Am J Cardiol. 2018 Mar 15;121(6):718-724
pubmed: 29373105
J Am Coll Cardiol. 2017 May 9;69(18):2317-2330
pubmed: 28473138
Autoimmun Rev. 2013 Jun;12(8):826-31
pubmed: 23219773
Lancet. 1993 Aug 7;342(8867):341-4
pubmed: 8101587
J Autoimmun. 2017 Jan;76:10-20
pubmed: 27776934
Autoimmun Rev. 2007 Jun;6(6):379-86
pubmed: 17537384